
Enanta Pharmaceuticals is a biotechnology business based in the US. Enanta Pharmaceuticals shares (ENTA) are listed on the NASDAQ and all prices are listed in US Dollars. Enanta Pharmaceuticals employs 160 staff and has a trailing 12-month revenue of around $86.2 million.
How to buy Enanta Pharmaceuticals stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – ENTA. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Enanta Pharmaceuticals stock price (NASDAQ: ENTA)
Use our graph to track the performance of ENTA stocks over time.Enanta Pharmaceuticals shares at a glance
Latest market close | $52.02 |
---|---|
52-week range | $37.59 - $79.50 |
50-day moving average | $45.82 |
200-day moving average | $52.22 |
Wall St. target price | $68.22 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-5.52 |
Buy Enanta Pharmaceuticals stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Enanta Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Enanta Pharmaceuticals price performance over time
Historical closes compared with the close of $52.02 from 2023-01-27
1 week (2023-01-24) | 0.39% |
---|---|
1 month (2022-12-30) | 11.82% |
3 months (2022-10-31) | 15.32% |
6 months (2022-07-29) | -5.68% |
1 year (2022-01-31) | -12.45% |
---|---|
2 years (2021-01-29) | 8.24% |
3 years (2020-01-31) | 0.93% |
5 years (2018-01-30) | 83.61 |
Enanta Pharmaceuticals financials
Revenue TTM | $86.2 million |
---|---|
Gross profit TTM | $86.2 million |
Return on assets TTM | -19.01% |
Return on equity TTM | -33.79% |
Profit margin | -141.31% |
Book value | $15.46 |
Market capitalisation | $1.1 billion |
TTM: trailing 12 months
Enanta Pharmaceuticals share dividends
We're not expecting Enanta Pharmaceuticals to pay a dividend over the next 12 months.
Enanta Pharmaceuticals share price volatility
Over the last 12 months, Enanta Pharmaceuticals's shares have ranged in value from as little as $37.59 up to $79.495. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Enanta Pharmaceuticals's is 0.3547. This would suggest that Enanta Pharmaceuticals's shares are less volatile than average (for this exchange).
Enanta Pharmaceuticals overview
Enanta Pharmaceuticals, Inc. , a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts. .
Enanta Pharmaceuticals in the news
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2023 Outlook at the 41st Annual J.P. Morgan Healthcare Conference
An Intrinsic Calculation For Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Suggests It's 49% Undervalued
Enanta Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
Frequently asked questions
What percentage of Enanta Pharmaceuticals is owned by insiders or institutions?Currently 6.382% of Enanta Pharmaceuticals shares are held by insiders and 95.406% by institutions. How many people work for Enanta Pharmaceuticals?
Latest data suggests 160 work at Enanta Pharmaceuticals. When does the fiscal year end for Enanta Pharmaceuticals?
Enanta Pharmaceuticals's fiscal year ends in September. Where is Enanta Pharmaceuticals based?
Enanta Pharmaceuticals's address is: 500 Arsenal Street, Watertown, MA, United States, 02472 What is Enanta Pharmaceuticals's ISIN number?
Enanta Pharmaceuticals's international securities identification number is: US29251M1062 What is Enanta Pharmaceuticals's CUSIP number?
Enanta Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 29251M106
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert